Immix Biopharma, Inc.
IMMX • NASDAQ
Immix Biopharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Ilya Rachman, with a market cap of $431.7M.
CEOIlya Rachman
Next Earnings
Upcoming earnings announcement for Immix Biopharma, Inc.
Date
Thursday, May 7, 2026 (in a month)
Timing
After Market Close (5:00 PM New York)
Fiscal Period
Q1 2026
EPS Estimate
-$0.20
Earnings History
Past 12 earnings reports for Immix Biopharma, Inc.
| Date | Period | EPS | EPS Surprise | Revenue | Rev. Surprise | Filing |
|---|---|---|---|---|---|---|
| Mar 25, 2026 | Q4 2025 | -$0.28Est: -$0.16 | -75.0% | - | — |  10-K/A |
| Nov 7, 2025 | Q3 2025 | -$0.24Est: -$0.18 | -33.3% | - | — | 10-Q |
| Aug 8, 2025 | Q2 2025 | -$0.22Est: -$0.16 | -37.5% | - | — | 10-Q |
| Nov 12, 2024 | Q3 2024 | -$0.24Est: -$0.16 | -50.0% | - | — | 10-Q |
| Aug 12, 2024 | Q2 2024 | -$0.15Est: -$0.21 | +28.6% | - | — | 10-Q |
| May 9, 2024 | Q1 2024 | -$0.22Est: -$0.23 | +4.3% | - | — | 10-Q |
| Mar 29, 2024 | Q4 2023 | -$0.24Est: -$0.23 | -4.3% | - | — | — |
| Nov 13, 2023 | Q3 2023 | -$0.23Est: -$0.23 | 0.0% | - | — | — |
| Aug 11, 2023 | Q2 2023 | -$0.24Est: -$0.17 | -41.2% | - | — | — |
| May 12, 2023 | Q1 2023 | -$0.18Est: -$0.14 | -28.6% | - | — | — |
| Mar 27, 2023 | Q4 2022 | -$0.27Est: -$0.22 | -22.7% | - | — | — |
| Nov 9, 2022 | Q3 2022 | -$0.11 | — | - | — | — |